Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Piani, F; Tossetta, G; Cara-Fuentes, G; Agnoletti, D; Marzioni, D; Borghi, C.
Diagnostic and Prognostic Role of CD93 in Cardiovascular Disease: A Systematic Review.
Biomolecules. 2023; 13(6):
Doi: 10.3390/biom13060910
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
- Autor*innen der Med Uni Graz:
- Piani Federica
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- INTRODUCTION: Cluster of Differentiation (CD) 93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp) is a transmembrane glycoprotein that can also be present in a soluble (sCD93) form. Recent studies have investigated the role of this protein in cardiovascular disease (CVD). The present systematic review aims to assess the associations between CD93 and cardiovascular (CV) risk factors and disease at both the proteomic and genomic levels. METHODS: We conducted systematic searches in the PubMed, EMBASE, and Web of Science databases to identify all human studies since inception to February 2023 that investigated the role of CD93 in CV risk factors, CVD, and CV-associated outcomes. The data collection and analysis have been independently conducted by two reviewers. The search terms included: cardiovascular, heart failure, acute stroke, myocardial infarction, stroke, peripheral artery disease, cardiovascular death, MACE, hypertension, metabolic syndrome, hyperuricemia, diabetes, cd93, c1qr, C1qR1, complement protein 1 q subcomponent receptor. RESULTS: A total of 182 references were identified, and 15 studies investigating the associations between CD93 protein levels or CD93 genetic polymorphisms and the development or prevalence of CV risk factors (i.e., hypertension, dyslipidemia, and obesity) and CVD (i.e., heart failure, coronary artery disease, and ischemic stroke) were included. Although promising, the quality and dimension of the analyzed studies do not allow for a definitive answer to the question of whether CD93 may hold diagnostic and prognostic value in CVD.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Cardiovascular Diseases - diagnosis, genetics
- Complement System Proteins - administration & dosage
- Heart Failure - administration & dosage
- Hypertension - administration & dosage
- Prognosis - administration & dosage
- Proteomics - administration & dosage